20/20 Biolabs Incの株価・株式情報

20/20 Biolabs Inc, formerly 20/20 GeneSystems, Inc., is a digital diagnostics company, which is engaged in developing and commercializing clinical laboratory tests and associated software that is powered by machine learning and real-word data to improve diagnostic accuracy and clinical usefulness. The Company offers OneTest, a simple blood test for multiple cancers, harnesses the power of Artificial Intelligence (AI) to help identify the disease at an earlier, more treatable stage. Onetest helps detect Lung, Liver, Pancreatic, Prostate, Kidney, Ovarian and many other cancers with a single blood test.